Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;2(1):21-2.
doi: 10.4161/chim.2.1.15057.

Split chimerism between nucleated and red blood cells after bone marrow transplantation for haemoglobinopathies

Affiliations

Split chimerism between nucleated and red blood cells after bone marrow transplantation for haemoglobinopathies

Marco Andreani et al. Chimerism. 2011 Jan.

Abstract

Previous studies have shown that a stable presence of both donor and recipient haematopoietic derived cells after allogeneic haematopoietic stem cell transplantation (HSCT) occurs in approximately ten percent of the patients affected by β-Thalassemia. Once achieved this condition, defined as persistent mixed chimerism (PMC), the patients do not require additional red blood cells (RBCs) support and, regardless of the presence in some cases of an extremely low percentage of donor-derived nucleated cells, they are clinically cured by an incomplete, but functional graft. Most of the published papers have, however, investigated the impact of donor engraftment in the nucleated cells rather than in the mature erythrocytes. We have recently published a paper showing that in four long-term transplanted patients affected by hemoglobinopathies, characterized by the presence of few donor engrafted nucleated cells-both in the peripheral blood and in the bone marrow-the majority of the erythrocytes were of donor origin. Moreover we showed that the proportion of donor-derived erythroid precursors, determined by analyzing singularly picked-up burst-forming unit erythroid colonies, was equivalent to that observed in the mature nucleated cells rather than in the red blood cells. These results suggest that in patients characterized by the presence of PMC after HSCT a selective advantage of the donor erythroid precursors maturation might successfully contrast the problems bound to the recipient ineffective erythropoiesis. When genetically modified HSCT will be a possible option for treating Thalassemia Major, the co-existence of the repaired cells with those still expressing the genetic defect will be an expected scenario, not in an allogeneic, but in an autologous environment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Engraftment evolution over time of a patient with persistent mixed chimerism. PB, peripheral blood; BM, bone marrow; RBCs, red blood cells, BFU-E (BM). Burst forming unit erythroid colonies obtained from bone marrow.

Comment on

References

    1. Weatheral DJ, Clegg JB. The Thalassemia Syndromes. 4th ed. Oxford: Blackwell Science; 2001.
    1. Modell B, Khan M, Darlison M. Survival in betathalassemia major in the UK: data from the UK Thalassemia Register. Lancet. 2000;355:2051–2052. - PubMed
    1. Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, et al. Survival and complications in thalassemia. Ann NY Acad Sci. 2005;1054:40–47. - PubMed
    1. Lucarelli G, Gaziev J. Advances in the allogeneic transplantation for thalassemia. Blood Rev. 2008;22:53–63. - PubMed
    1. Andreani M, Testi M, Battarra M, Indigeno P, Guagnano A, Polchi P, et al. Relationship between mixed chimerism and rejection after bone marrow transplantation in thalassaemia. Blood Transfu. 2008;6:143–149. - PMC - PubMed

LinkOut - more resources